Re: Patience
|
10
|
Resverlogix Corp.
|
Jan 19, 2022 01:15AM
|
Re: Patience
|
14
|
Resverlogix Corp.
|
Jun 20, 2021 12:34PM
|
Re: Pfizer Paxlovid
|
3
|
Resverlogix Corp.
|
Jan 01, 2022 05:00PM
|
Re: Please help
|
6
|
Resverlogix Corp.
|
Apr 01, 2021 12:49AM
|
Re: Please keep post respectful
|
6
|
Resverlogix Corp.
|
Jan 24, 2021 08:10PM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
3
|
Resverlogix Corp.
|
Nov 18, 2022 08:12PM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
1
|
Resverlogix Corp.
|
Nov 19, 2022 10:04PM
|
Re: Presentation is gone - Nose growing
|
4
|
Resverlogix Corp.
|
May 17, 2021 08:30AM
|
Re: Question for posters
|
6
|
Resverlogix Corp.
|
Dec 10, 2021 12:50AM
|
Re: Question for posters
|
4
|
Resverlogix Corp.
|
Dec 10, 2021 08:30AM
|
Re: Question re BOD votes
|
2
|
Resverlogix Corp.
|
Jul 02, 2022 09:23AM
|
Re: Question to ask at the AGM
|
3
|
Resverlogix Corp.
|
Oct 30, 2019 07:49PM
|
Re: Radio message, maybe Apabetalone
|
2
|
Resverlogix Corp.
|
Apr 27, 2021 08:55AM
|
Re: Response from Sarah -were still a go
|
3
|
Resverlogix Corp.
|
Dec 05, 2021 01:29AM
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
7
|
Resverlogix Corp.
|
Apr 01, 2020 10:06AM
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
5
|
Resverlogix Corp.
|
Jun 23, 2022 09:09AM
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
6
|
Resverlogix Corp.
|
Feb 17, 2022 10:01PM
|
Re: Rigel Pharma - an interesting parallel?
|
3
|
Resverlogix Corp.
|
May 28, 2021 09:34PM
|
Re: Rules of thumb and broken thumbs...
|
5
|
Resverlogix Corp.
|
Sep 29, 2020 12:28AM
|
Re: Rules of thumb and broken thumbs...
|
7
|
Resverlogix Corp.
|
Sep 30, 2020 09:00AM
|